High Tower Advisors, LLC Ironwood Pharmaceuticals Inc Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$8.79 - $11.51 $16,252 - $21,281	1,849 Added 3.66%	52,339 $598,000
Q3 2023 Nov 08, 2023	BUY	$8.25 - $11.35 $136,265 - $187,467	16,517 Added 48.62%	50,490 $486,000
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $12,968 - $14,894	1,284 Added 3.93%	33,973 $361,000
Q1 2023 May 11, 2023	BUY	$10.37 - $12.56 $338,984 - $410,573	32,689 New	32,689 $343,000
Q2 2021 Aug 06, 2021	SELL	$10.16 - $13.11 $1.16 Million - $1.5 Million	-114,480 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$9.04 - $11.86 $1.03 Million - $1.36 Million	114,480 New	114,480 $1.28 Million

245

163M

11.5M

12.9K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $236M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.